Clinical Trials Browser

Phase 2 × Multiple Myeloma × cemiplimab × Clear all

NCT05669989 2025-01-23

International Treatment-extension Study in Adult Participants With Multiple Myeloma and Who Have Derived Clinical Benefit From Isatuximab

Phase 2 Active not recruiting

Multiple Myeloma